Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By Workflow
2.3.2 Market Size By Service
2.3.3 Market Size By Therapeutics Area
2.3.4 Market Size By End Use
2.4 Market Share & BPS Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Outsourcing & Cost Trends
4.1.1 Country-wise Outsourcing Cost Benchmarking
4.1.2 Cost-Efficiency Gains from Outsourcing
4.2 R&D Investment and Funding Trends
4.2.1 Venture Capital and M&A Activity in Discovery-Focused CROs (2020–2024)
4.2.2 Pharma-Biotech R&D Outsourcing Ratios
4.3 Technology Adoption Trends
4.3.1 AI and Machine Learning in Drug Discovery Pipelines
4.3.2 Adoption of Cloud-Based Chemistry & Virtual Collaboration Platforms
4.4 Pipeline Acceleration Metrics
4.4.1 Preclinical to IND Timeline Compression via Outsourcing
4.4.2 Hit-to-Lead Success Rate Improvements by Outsourcing Partners
4.5 Market Penetration and Capacity Utilization
4.5.1 Capacity Utilization Rates of Top CROs
4.5.2 Growth in Outsourcing Demand by Therapeutic Area
5. Small Molecule Drug Discovery Outsourcing Market Segmental Analysis & Forecast, By Workflow, 2021 – 2032, Value (USD Billion)
5.1 Introduction
5.2 Target Identification & Screening
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.3 Target Validation & Functional Informatics
5.3.1 Key Trends
5.3.2 Market Size & Forecast, 2021 – 2032
5.4 Lead Identification & Candidate Optimization
5.4.1 Key Trends
5.4.2 Market Size & Forecast, 2021 – 2032
5.5 Preclinical Development
5.5.1 Key Trends
5.5.2 Market Size & Forecast, 2021 – 2032
5.6 Others (Hit-to-Lead Studies, In Silico Modeling / Computational Drug Design)
5.6.1 Key Trends
5.6.2 Market Size & Forecast, 2021 – 2032
6. Small Molecule Drug Discovery Outsourcing Market Segmental Analysis & Forecast, By Service, 2021 – 2032, Value (USD Billion)
6.1 Introduction
6.2 Chemistry Services
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.3 Biology Services
6.3.1 Key Trends
6.3.2 Market Size & Forecast, 2021 – 2032
6.4 Others (DMPK (Drug Metabolism and Pharmacokinetics) Services, Toxicology Screening Services)
6.4.1 Key Trends
6.4.2 Market Size & Forecast, 2021 – 2032
7. Small Molecule Drug Discovery Outsourcing Market Segmental Analysis & Forecast, By Therapeutics Area, 2021 – 2032, Value (USD Billion)
7.1 Introduction
7.2 Respiratory system
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2021 – 2032
7.3 Pain and Anesthesia
7.3.1 Key Trends
7.3.2 Market Size & Forecast, 2021 – 2032
7.4 Oncology
7.4.1 Key Trends
7.4.2 Market Size & Forecast, 2021 – 2032
7.5 Ophthalmology
7.5.1 Key Trends
7.5.2 Market Size & Forecast, 2021 – 2032
7.6 Hematology
7.6.1 Key Trends
7.6.2 Market Size & Forecast, 2021 – 2032
7.7 Cardiovascular
7.7.1 Key Trends
7.7.2 Market Size & Forecast, 2021 – 2032
7.8 Endocrine
7.8.1 Key Trends
7.8.2 Market Size & Forecast, 2021 – 2032
7.9 Gastrointestinal
7.9.1 Key Trends
7.9.2 Market Size & Forecast, 2021 – 2032
7.10 Immunomodulation
7.10.1 Key Trends
7.10.2 Market Size & Forecast, 2021 – 2032
7.11 Anti-infective
7.11.1 Key Trends
7.11.2 Market Size & Forecast, 2021 – 2032
7.12 Central Nervous System
7.12.1 Key Trends
7.12.2 Market Size & Forecast, 2021 – 2032
7.13 Dermatology
7.12.1 Key Trends
7.12.2 Market Size & Forecast, 2021 – 2032
7.14 Genitourinary System
7.12.1 Key Trends
7.12.2 Market Size & Forecast, 2021 – 2032
7.15 Others (Rare/Orphan Diseases, Autoimmune Disorders, Metabolic Disorders)
7.12.1 Key Trends
7.12.2 Market Size & Forecast, 2021 – 2032
8. Small Molecule Drug Discovery Outsourcing Market Segmental Analysis & Forecast, By End Use, 2021 – 2032, Value (USD Billion)
8.1 Introduction
8.2 Pharmaceutical & Biotechnology companies
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2021 – 2032
8.3 Academic Institutes
8.3.1 Key Trends
8.3.2 Market Size & Forecast, 2021 – 2032
8.4 Others (Contract Research Organizations (CROs), Research Institutions, Non-Profit Research Foundations)
8.4.1 Key Trends
8.4.2 Market Size & Forecast, 2021 – 2032
9. Small Molecule Drug Discovery Outsourcing Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.2.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.2.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.2.5 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.2.6 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Country, 2021 – 2032
9.2.6.1 USA
9.2.6.1.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.2.6.1.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.2.6.1.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.2.6.1.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.2.6.2 Canada
9.2.6.2.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.2.6.2.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.2.6.2.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.2.6.2.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.3 Europe
9.3.1 Key Trends
9.3.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.3.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.3.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.3.5 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.3.6 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Country, 2021 – 2032
9.3.6.1 Germany
9.3.6.1.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.3.6.1.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.3.6.1.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.3.6.1.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.2 UK
9.3.6.2.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.3.6.2.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.3.6.2.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.3.6.2.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.3 France
9.3.6.3.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.3.6.3.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.3.6.3.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.3.6.3.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.4 Italy
9.3.6.4.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.3.6.4.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.3.6.4.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.3.6.4.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.5 Spain
9.3.6.5.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.3.6.5.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.3.6.5.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.3.6.5.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.6 Russia
9.3.6.6.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.3.6.6.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.3.6.6.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.3.6.6.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.7 Poland
9.3.6.7.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.3.6.7.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.3.6.7.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.3.6.7.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.3.6.8 Rest of Europe
9.3.6.8.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.3.6.8.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.3.6.8.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.3.6.8.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.4.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.4.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.4.5 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.4.6 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Country, 2021 – 2032
9.4.6.1 China
9.4.6.1.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.4.6.1.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.4.6.1.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.4.6.1.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.2 India
9.4.6.2.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.4.6.2.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.4.6.2.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.4.6.2.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.3 Japan
9.4.6.3.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.4.6.3.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.4.6.3.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.4.6.3.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.4 South Korea
9.4.6.4.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.4.6.4.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.4.6.4.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.4.6.4.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.5 Australia
9.4.6.5.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.4.6.5.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.4.6.5.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.4.6.5.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.6 ASEAN Countries
9.4.6.6.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.4.6.6.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.4.6.6.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.4.6.6.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.4.6.7 Rest of Asia-Pacific
9.4.6.7.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.4.6.7.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.4.6.7.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.4.6.7.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.5 Latin America
9.5.1 Key Trends
9.5.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.5.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.5.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.5.5 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.5.6 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Country, 2021 – 2032
9.5.6.1 Brazil
9.5.6.1.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.5.6.1.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.5.6.1.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.5.6.1.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.5.6.2 Argentina
9.5.6.2.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.5.6.2.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.5.6.2.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.5.6.2.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.5.6.3 Mexico
9.5.6.3.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.5.6.3.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.5.6.3.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.5.6.3.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.5.6.4 Colombia
9.5.6.4.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.5.6.4.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.5.6.4.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.5.6.4.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.5.6.5 Rest of Latin America
9.5.6.5.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.5.6.5.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.5.6.5.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.5.6.5.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.6.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.6.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.6.5 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.6.6 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Country, 2021 – 2032
9.6.6.1 UAE
9.6.6.1.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.6.6.1.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.6.6.1.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.6.6.1.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.6.6.2 Saudi Arabia
9.6.6.2.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.6.6.2.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.6.6.2.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.6.6.2.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.6.6.3 Qatar
9.6.6.3.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.6.6.3.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.6.6.3.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.6.6.3.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.6.6.4 Egypt
9.6.6.4.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.6.6.4.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.6.6.4.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.6.6.4.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.6.6.5 South Africa
9.6.6.5.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.6.6.5.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.6.6.5.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.6.6.5.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
9.6.6.6 Rest of Middle East & Africa
9.6.6.6.1 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Workflow, 2021 – 2032
9.6.6.6.2 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Service, 2021 – 2032
9.6.6.6.3 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By Therapeutics Area, 2021 – 2032
9.6.6.6.4 Small Molecule Drug Discovery Outsourcing Market Size & Forecast, By End Use, 2021 – 2032
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2024
10.2.2 Year-Wise Strategies & Development, 2021 – 2025
10.2.3 Number of Strategies Adopted by Key Players, 2024
10.3 Market Share Analysis, 2024
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6 Key Company Profiles
10.6.1 WuXi AppTec
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Pharmaceutical Product Development LLC (PPD)
10.6.2.1 Company Overview & Snapshot
10.6.2.2 Product/Service Portfolio
10.6.2.3 Key Company Financials
10.6.2.4 SWOT Analysis
10.6.3 Charles River Laboratories
10.6.3.1 Company Overview & Snapshot
10.6.3.2 Product/Service Portfolio
10.6.3.3 Key Company Financials
10.6.3.4 SWOT Analysis
10.6.4 Laboratory Corporation of America Holdings (Covance)
10.6.4.1 Company Overview & Snapshot
10.6.4.2 Product/Service Portfolio
10.6.4.3 Key Company Financials
10.6.4.4 SWOT Analysis
10.6.5 Eurofins Scientific
10.6.5.1 Company Overview & Snapshot
10.6.5.2 Product/Service Portfolio
10.6.5.3 Key Company Financials
10.6.5.4 SWOT Analysis
10.6.6 Evotec SE
10.6.6.1 Company Overview & Snapshot
10.6.6.2 Product/Service Portfolio
10.6.6.3 Key Company Financials
10.6.6.4 SWOT Analysis
10.6.7 Curia (Albany Molecular Research Inc.)
10.6.7.1 Company Overview & Snapshot
10.6.7.2 Product/Service Portfolio
10.6.7.3 Key Company Financials
10.6.7.4 SWOT Analysis
10.6.8 GenScript Biotech
10.6.8.1 Company Overview & Snapshot
10.6.8.2 Product/Service Portfolio
10.6.8.3 Key Company Financials
10.6.8.4 SWOT Analysis
10.6.9 Pharmaron Beijing Co.
10.6.9.1 Company Overview & Snapshot
10.6.9.2 Product/Service Portfolio
10.6.9.3 Key Company Financials
10.6.9.4 SWOT Analysis
10.6.10 Syngene International Ltd.
10.6.10.1 Company Overview & Snapshot
10.6.10.2 Product/Service Portfolio
10.6.10.3 Key Company Financials
10.6.10.4 SWOT Analysis
10.6.11 Dalton Pharma Services
10.6.11.1 Company Overview & Snapshot
10.6.11.2 Product/Service Portfolio
10.6.11.3 Key Company Financials
10.6.11.4 SWOT Analysis
10.6.12 Oncodesign Services
10.6.12.1 Company Overview & Snapshot
10.6.12.2 Product/Service Portfolio
10.6.12.3 Key Company Financials
10.6.12.4 SWOT Analysis
10.6.13 Jubilant Biosys Ltd.
10.6.13.1 Company Overview & Snapshot
10.6.13.2 Product/Service Portfolio
10.6.13.3 Key Company Financials
10.6.13.4 SWOT Analysis
10.6.14 Domainex Ltd.
10.6.14.1 Company Overview & Snapshot
10.6.14.2 Product/Service Portfolio
10.6.14.3 Key Company Financials
10.6.14.4 SWOT Analysis
10.6.15 Merck & Co., Inc.
10.6.15.1 Company Overview & Snapshot
10.6.15.2 Product/Service Portfolio
10.6.15.3 Key Company Financials
10.6.15.4 SWOT Analysis
10.6.16 QIAGEN N.V.
10.6.16.1 Company Overview & Snapshot
10.6.16.2 Product/Service Portfolio
10.6.16.3 Key Company Financials
10.6.16.4 SWOT Analysis
10.6.17 Dr. Reddy’s Laboratories Ltd.
10.6.17.1 Company Overview & Snapshot
10.6.17.2 Product/Service Portfolio
10.6.17.3 Key Company Financials
10.6.17.4 SWOT Analysis
10.6.18 TCG Lifesciences Pvt. Ltd.
10.6.18.1 Company Overview & Snapshot
10.6.18.2 Product/Service Portfolio
10.6.18.3 Key Company Financials
10.6.18.4 SWOT Analysis
10.6.19 Aurigene Pharmaceutical Services
10.6.19.1 Company Overview & Snapshot
10.6.19.2 Product/Service Portfolio
10.6.19.3 Key Company Financials
10.6.19.4 SWOT Analysis
10.6.20 Medpace Inc
10.6.20.1 Company Overview & Snapshot
10.6.20.2 Product/Service Portfolio
10.6.20.3 Key Company Financials
10.6.20.4 SWOT Analysis
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
